Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang-shui Li

Showing results (1-10 of 1) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|May 6, 2015
Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatmentGuo-Jun Li, Yi-Qi Yu, Shao-Long Chen, et al.
Pageof 1

Showing results (1-10 of 1) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|May 6, 2015
Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatmentGuo-Jun Li, Yi-Qi Yu, Shao-Long Chen, et al.
Pageof 1